EDIT
Editas Medicine, Inc.
- Latest sale
- $1k
- Sep 3 · Routine
- Form 4 sales
- 157
- On record
- Form 144 notices
- 2
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineJun 3 2026
Sold 731 shares at $2.70 ($2k)
Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER
10b5-1 planSold 1.1% of holdings ($184k position)67,297 shares left1x usual sizeFiling
- 2 Form 4 saleRoutineJun 3 same day
Sold 15,380 shares at $2.70 ($42k)
O'Neill Gilmore Neil, CEO
10b5-1 planSold 5.8% of holdings ($712k position)248,313 shares left2.7x usual sizeFiling
- 3 Form 4 saleRoutineJun 3 same day
Sold 464 shares at $2.70 ($1k)
Parison Amy, SVP, Chief Financial Officer
10b5-1 planSold 3% of holdings ($42k position)14,970 shares left1x usual sizeFiling
- 4 Form 4 saleUnusualJul 28 +55 days
Sold 4,928 shares at $2.67 ($13k)
Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER
10b5-1 planSold 7.3% of holdings ($180k position)62,369 shares left6.7x usual sizeFiling
- 5 Form 4 saleRoutineAug 3 +6 days
Sold 678 shares at $2.58 ($2k)
Parison Amy, SVP, Chief Financial Officer
10b5-1 planSold 4.5% of holdings ($39k position)14,292 shares left1.5x usual sizeFiling
- 6 Form 4 saleRoutineSep 3 +31 days
Sold 5,124 shares at $3.04 ($16k)
O'Neill Gilmore Neil, CEO
10b5-1 planSold 2.1% of holdings ($755k position)243,189 shares left0.9x usual sizeFiling
- 7 Form 4 saleRoutineSep 3 same day
Sold 709 shares at $3.04 ($2k)
Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER
10b5-1 planSold 1.1% of holdings ($190k position)61,660 shares left1x usual sizeFiling
- 8 Form 4 saleRoutineSep 3 same day
Sold 453 shares at $3.04 ($1k)
Parison Amy, SVP, Chief Financial Officer
10b5-1 planSold 3.2% of holdings ($43k position)13,839 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (159)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Parison Amy | SVP, Chief Financial Officer | Form 4 sale | 453 | $1k | 3.2% | Routine | SEC |
| Sep 3, 2026 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 709 | $2k | 1.1% | Routine | SEC |
| Sep 3, 2026 | O'Neill Gilmore Neil | CEO | Form 4 sale | 5,124 | $16k | 2.1% | Routine | SEC |
| Aug 3, 2026 | Parison Amy | SVP, Chief Financial Officer | Form 4 sale | 678 | $2k | 4.5% | Routine | SEC |
| Jul 28, 2026 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 4,928 | $13k | 7.3% | Unusual | SEC |
| Jun 3, 2026 | Parison Amy | SVP, Chief Financial Officer | Form 4 sale | 464 | $1k | 3.0% | Routine | SEC |
| Jun 3, 2026 | O'Neill Gilmore Neil | CEO | Form 4 sale | 15,380 | $42k | 5.8% | Routine | SEC |
| Jun 3, 2026 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 731 | $2k | 1.1% | Routine | SEC |
| Mar 3, 2026 | O'Neill Gilmore Neil | CEO | Form 4 sale | 5,394 | $11k | 2.0% | Routine | SEC |
| Mar 3, 2026 | Parison Amy | SVP, Chief Financial Officer | Form 4 sale | 474 | $957 | 3.0% | Routine | SEC |
| Mar 3, 2026 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 749 | $2k | 1.1% | Routine | SEC |
| Dec 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 713 | $2k | 1.0% | Routine | SEC |
| Dec 3, 2025 | O'Neill Gilmore Neil | CEO | Form 4 sale | 5,603 | $12k | 2.0% | Routine | SEC |
| Dec 3, 2025 | Parison Amy | SVP, Chief Financial Officer | Form 4 sale | 461 | $991 | 2.8% | Routine | SEC |
| Sep 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 710 | $2k | 1.0% | Routine | SEC |
| Sep 3, 2025 | Parison Amy | SVP, Chief Financial Officer | Form 4 sale | 458 | $1k | 2.7% | Routine | SEC |
| Sep 3, 2025 | O'Neill Gilmore Neil | CEO | Form 4 sale | 5,592 | $15k | 2.0% | Routine | SEC |
| Aug 7, 2025 | Parison Amy | SVP, Chief Financial Officer | Form 4 sale | 679 | $2k | 3.9% | Routine | SEC |
| Jul 31, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 5,121 | $13k | 7.4% | Routine | SEC |
| Jun 3, 2025 | Parison Amy | SVP, Chief Financial Officer | Form 4 sale | 446 | $767 | 2.5% | Routine | SEC |
| Jun 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 726 | $1k | 1.0% | Routine | SEC |
| Jun 3, 2025 | O'Neill Gilmore Neil | CEO | Form 4 sale | 15,192 | $26k | 5.1% | Routine | SEC |
| Mar 4, 2025 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 4,109 | $7k | 3.5% | Routine | SEC |
| Mar 4, 2025 | O'Neill Gilmore Neil | CEO | Form 4 sale | 16,632 | $28k | 5.3% | Routine | SEC |
| Mar 4, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 2,891 | $5k | 4.0% | Routine | SEC |
| Dec 3, 2024 | O'Neill Gilmore Neil | CEO | Form 4 sale | 1,618 | $3k | 0.5% | Routine | SEC |
| Dec 3, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Form 4 sale | 541 | $1k | 0.4% | Routine | SEC |
| Sep 4, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Form 4 sale | 518 | $2k | 0.4% | Routine | SEC |
| Sep 4, 2024 | O'Neill Gilmore Neil | CEO | Form 4 sale | 1,555 | $5k | 0.5% | Routine | SEC |
| Jul 25, 2024 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 11,886 | $64k | 14.0% | Routine | SEC |
| Jul 19, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Form 4 sale | 6,619 | $34k | 4.7% | Routine | SEC |
| Jun 4, 2024 | O'Neill Gilmore Neil | CEO | Form 4 sale | 12,191 | $67k | 3.7% | Routine | SEC |
| Jun 4, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Form 4 sale | 511 | $3k | 0.4% | Routine | SEC |
| May 20, 2024 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 22,337 | $125k | 16.1% | Routine | SEC |
| Mar 5, 2024 | O'Neill Gilmore Neil | CEO | Form 4 sale | 77,824 | $733k | 19.2% | Routine | SEC |
| Mar 4, 2024 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Form 4 sale | 20,327 | $191k | 12.6% | Routine | SEC |
| Dec 5, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 103 | $1k | 0.1% | Routine | SEC |
| Nov 14, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 695 | $6k | 0.9% | Routine | SEC |
| Nov 7, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 139 | $1k | 0.2% | Routine | SEC |
| Sep 6, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 103 | $908 | 0.1% | Routine | SEC |
| Aug 11, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 702 | $6k | 0.9% | Routine | SEC |
| Aug 8, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 141 | $1k | 0.2% | Routine | SEC |
| Jul 19, 2023 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Form 4 sale | 4,317 | $38k | 5.7% | Routine | SEC |
| Jun 5, 2023 | O'Neill Gilmore Neil | CEO | Form 4 sale | 6,486 | $62k | 4.7% | Routine | SEC |
| Jun 5, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 105 | $998 | 0.1% | Routine | SEC |
| Jun 2, 2023 | O'Neill Gilmore Neil | Officer, Director | Form 144 notice | 8,500 | $78k | Notice | SEC | |
| May 11, 2023 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 949 | $9k | 0.9% | Routine | SEC |
| May 11, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 668 | $7k | 0.9% | Routine | SEC |
| May 11, 2023 | Robertson Michelle | Officer | Form 144 notice | 3,000 | $11k | Notice | SEC | |
| May 9, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 135 | $1k | 0.2% | Routine | SEC |
| Mar 3, 2023 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 184 | $2k | 0.2% | Plan not stated | SEC |
| Mar 3, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 101 | $898 | 0.1% | Plan not stated | SEC |
| Feb 13, 2023 | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 2,790 | $27k | 4.1% | Plan not stated | SEC |
| Feb 13, 2023 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 4,287 | $41k | 5.3% | Plan not stated | SEC |
| Feb 13, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 3,307 | $32k | 5.1% | Unusual | SEC |
| Feb 7, 2023 | Eaton Bruce | EVP, CBO AND CTO | Form 4 sale | 346 | $4k | 0.5% | Plan not stated | SEC |
| Jan 10, 2023 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 1,752 | $14k | 2.1% | Plan not stated | SEC |
| Dec 5, 2022 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 193 | $2k | 0.2% | Plan not stated | SEC |
| Dec 5, 2022 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Form 4 sale | 102 | $1k | 0.2% | Plan not stated | SEC |
| Nov 8, 2022 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Form 4 sale | 289 | $3k | 0.4% | Plan not stated | SEC |
| Sep 6, 2022 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 192 | $3k | 0.2% | Plan not stated | SEC |
| Sep 6, 2022 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Form 4 sale | 101 | $2k | 0.2% | Plan not stated | SEC |
| Aug 9, 2022 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Form 4 sale | 293 | $5k | 0.4% | Plan not stated | SEC |
| Jun 15, 2022 | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | Form 4 sale | 5,145 | $52k | 7.0% | Plan not stated | SEC |
| Jun 3, 2022 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Form 4 sale | 1,123 | $13k | 1.7% | Unusual | SEC |
| Jun 3, 2022 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 1,527 | $18k | 1.8% | Plan not stated | SEC |
| May 9, 2022 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Form 4 sale | 297 | $4k | 0.4% | Plan not stated | SEC |
| Apr 1, 2022 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Form 4 sale | 1,545 | $41k | 2.3% | Plan not stated | SEC |
| Mar 3, 2022 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Form 4 sale | 403 | $7k | 0.6% | Plan not stated | SEC |
| Mar 3, 2022 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 767 | $13k | 0.9% | Plan not stated | SEC |
| Feb 8, 2022 | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Form 4 sale | 302 | $5k | 1.0% | Plan not stated | SEC |
| Jan 11, 2022 | Robertson Michelle | Chief Financial Officer | Form 4 sale | 1,744 | $45k | 5.3% | Plan not stated | SEC |
| Jan 3, 2022 | Mullen James C | CEO | Form 4 sale | 18,252 | $492k | 19.4% | Plan not stated | SEC |
| Nov 12, 2021 | Michaels Lisa Anne | EVP/Chief Medical Officer | Form 4 sale | 1,568 | $60k | 7.8% | Plan not stated | SEC |
| Nov 9, 2021 | Eaton Bruce | EVP, Chief Business Officer | Form 4 sale | 287 | $12k | 1.0% | Plan not stated | SEC |
| Oct 18, 2021 | Mullen James C | CEO | Form 4 sale | 13,805 | $525k | 19.3% | Plan not stated | SEC |
| Aug 9, 2021 | Robertson Michelle | Chief Financial Officer | Form 4 sale | 2,500 | $150k | 8.0% | Plan not stated | SEC |
| Jun 28, 2021 | Robertson Michelle | Chief Financial Officer | Form 4 sale | 2,500 | $125k | 8.0% | Plan not stated | SEC |
| Feb 9, 2021 | Collins Cynthia | CEO | Form 4 sale | 1,262 | $84k | 2.8% | Plan not stated | SEC |
| Jan 12, 2021 | Robertson Michelle | Chief Financial Officer | Form 4 sale | 1,568 | $123k | 7.8% | Plan not stated | SEC |
| Dec 15, 2020 | Albright Charles | EVP/Chief Scientific Officer | Form 4 sale | 10,000 | $632k | 28.6% | Unusual | SEC |
| Dec 9, 2020 | Albright Charles | EVP/Chief Scientific Officer | Form 4 sale | 10,000 | $450k | 28.6% | Unusual | SEC |
| Dec 7, 2020 | Albright Charles | EVP/Chief Scientific Officer | Form 4 sale | 20,000 | $800k | 44.5% | Unusual | SEC |
| Nov 9, 2020 | Albright Charles | EVP/Chief Scientific Officer | Form 4 sale | 228 | $7k | 0.9% | Plan not stated | SEC |
| Oct 15, 2020 | Albright Charles | EVP/Chief Scientific Officer | Form 4 sale | 3,000 | $94k | 10.7% | Plan not stated | SEC |
| Aug 20, 2020 | Collins Cynthia | CEO | Form 4 sale | 1,976 | $72k | 4.2% | Plan not stated | SEC |
| Aug 17, 2020 | Albright Charles | EVP/Chief Scientific Officer | Form 4 sale | 10,000 | $353k | 26.2% | Unusual | SEC |
| Aug 7, 2020 | Albright Charles | EVP/Chief Scientific Officer | Form 4 sale | 10,238 | $383k | 26.7% | Unusual | SEC |
| Jul 15, 2020 | Albright Charles | EVP/Chief Scientific Officer | Form 4 sale | 3,000 | $97k | 9.6% | Unusual | SEC |
| May 6, 2020 | Albright Charles | EVP/Chief Scientific Officer | Form 4 sale | 151 | $4k | 0.5% | Plan not stated | SEC |
| Feb 7, 2020 | Albright Charles | Chief Scientific Officer | Form 4 sale | 622 | $17k | 1.9% | Plan not stated | SEC |
| Feb 3, 2020 | Albright Charles | Chief Scientific Officer | Form 4 sale | 5,549 | $147k | 21.3% | Plan not stated | SEC |
| Aug 19, 2019 | Collins Cynthia | CEO | Form 4 sale | 5,193 | $134k | 31.3% | Unusual | SEC |
| Mar 18, 2019 | Myer Vickesh | Chief Technology Officer | Form 4 sale | 3,000 | $74k | 100.0% | Unusual | SEC |
| Feb 20, 2019 | Myer Vickesh | Chief Technology Officer | Form 4 sale | 3,000 | $61k | 100.0% | Unusual | SEC |
| Feb 4, 2019 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 6,895 | $147k | 100.0% | Unusual | SEC |
| Jan 18, 2019 | Myer Vickesh | Chief Technology Officer | Form 4 sale | 7,000 | $185k | 100.0% | Unusual | SEC |
| Jan 8, 2019 | Bosley Katrine | President and CEO | Form 4 sale | 12,000 | $303k | 1.0% | Plan not stated | SEC |
| Jan 4, 2019 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 7,000 | $157k | 100.0% | Unusual | SEC |
| Dec 18, 2018 | Myer Vickesh | Chief Technology Officer | Form 4 sale | 7,000 | $193k | 100.0% | Unusual | SEC |
| Dec 3, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 12,000 | $383k | 1.0% | Plan not stated | SEC |
| Nov 23, 2018 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 5,284 | $149k | 100.0% | Unusual | SEC |
| Nov 20, 2018 | Myer Vickesh | Chief Technology Officer | Form 4 sale | 7,000 | $191k | 100.0% | Unusual | SEC |
| Nov 1, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 12,000 | $323k | 1.0% | Plan not stated | SEC |
| Oct 26, 2018 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 6,000 | $154k | 100.0% | Unusual | SEC |
| Oct 18, 2018 | Myer Vickesh | Chief Technology Officer | Form 4 sale | 7,000 | $204k | 100.0% | Unusual | SEC |
| Oct 1, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 12,000 | $372k | 1.0% | Plan not stated | SEC |
| Sep 28, 2018 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 8,000 | $257k | 100.0% | Unusual | SEC |
| Sep 18, 2018 | Myer Vickesh | Chief Technology Officer | Form 4 sale | 7,000 | $226k | 100.0% | Unusual | SEC |
| Sep 4, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 12,000 | $388k | 0.9% | Plan not stated | SEC |
| Aug 31, 2018 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 10,000 | $322k | 100.0% | Unusual | SEC |
| Aug 20, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 12,000 | $362k | 0.9% | Plan not stated | SEC |
| Aug 20, 2018 | Myer Vickesh | Chief Technology Officer | Form 4 sale | 7,000 | $208k | 100.0% | Unusual | SEC |
| Aug 1, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 8,333 | $246k | 0.6% | Plan not stated | SEC |
| Jul 18, 2018 | Myer Vickesh | Chief Technology Officer | Form 4 sale | 14,000 | $499k | 100.0% | Unusual | SEC |
| Jul 2, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 8,333 | $302k | 0.6% | Plan not stated | SEC |
| Jun 19, 2018 | Myer Vickesh | Chief Technology Officer | Form 4 sale | 14,000 | $536k | 100.0% | Unusual | SEC |
| Jun 13, 2018 | Albright Charles | Chief Scientific Officer | Form 4 sale | 10,000 | $360k | 100.0% | Unusual | SEC |
| Jun 4, 2018 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 10,000 | $386k | 100.0% | Unusual | SEC |
| Jun 1, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 8,333 | $313k | 0.6% | Plan not stated | SEC |
| May 23, 2018 | Albright Charles | Chief Scientific Officer | Form 4 sale | 10,000 | $350k | 100.0% | Unusual | SEC |
| May 1, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 8,333 | $266k | 0.6% | Plan not stated | SEC |
| Apr 2, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 8,333 | $268k | 0.6% | Plan not stated | SEC |
| Mar 20, 2018 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 40,000 | $1.5M | 100.0% | Unusual | SEC |
| Mar 9, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 9,134 | $411k | 0.7% | Plan not stated | SEC |
| Mar 1, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 8,333 | $298k | 0.6% | Plan not stated | SEC |
| Feb 16, 2018 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 18,000 | $616k | 100.0% | Unusual | SEC |
| Feb 1, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 8,333 | $301k | 0.6% | Plan not stated | SEC |
| Jan 30, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 20,000 | $776k | 1.5% | Plan not stated | SEC |
| Jan 23, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 3,338 | $118k | 0.2% | Plan not stated | SEC |
| Jan 3, 2018 | Bosley Katrine | President and CEO | Form 4 sale | 14,995 | $512k | 1.1% | Plan not stated | SEC |
| Dec 19, 2017 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 14,649 | $361k | 100.0% | Unusual | SEC |
| Dec 1, 2017 | Bosley Katrine | President and CEO | Form 4 sale | 8,333 | $247k | 0.6% | Plan not stated | SEC |
| Nov 20, 2017 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 10,000 | $251k | 100.0% | Unusual | SEC |
| Nov 1, 2017 | Bosley Katrine | President and CEO | Form 4 sale | 8,333 | $197k | 0.6% | Plan not stated | SEC |
| Oct 2, 2017 | Bosley Katrine | President and CEO | Form 4 sale | 8,333 | $207k | 0.6% | Plan not stated | SEC |
| Sep 5, 2017 | Bosley Katrine | President and CEO | Form 4 sale | 16,666 | $339k | 1.2% | Plan not stated | SEC |
| Aug 11, 2017 | Bosley Katrine | President and CEO | Form 4 sale | 16,666 | $334k | 1.2% | Plan not stated | SEC |
| May 22, 2017 | Bitterman Kevin | Director | Form 4 sale | 1M | $17M | 26.3% | Unusual | SEC |
| Mar 15, 2017 | Glucksmann Alexandra | Chief Operating Officer | Form 4 sale | 1,000 | $26k | 0.8% | Plan not stated | SEC |
| Feb 15, 2017 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 3,000 | $58k | 100.0% | Unusual | SEC |
| Feb 15, 2017 | Glucksmann Alexandra | Chief Operating Officer | Form 4 sale | 6,000 | $123k | 4.8% | Plan not stated | SEC |
| Jan 11, 2017 | Hack Andrew A. F. | Chief Financial Officer | Form 4 sale | 15,000 | $288k | 100.0% | Unusual | SEC |
| Dec 7, 2016 | Bitterman Kevin | Director, 10% owner | Form 4 sale | 75,000 | $1.2M | 1.9% | Plan not stated | SEC |
| Dec 7, 2016 | Polaris Venture Partners VI, L.P. | 10% owner | Form 4 sale | 75,000 | $1.2M | 1.9% | Plan not stated | SEC |
| Dec 6, 2016 | Polaris Venture Partners VI, L.P. | 10% owner | Form 4 sale | 130,000 | $2.1M | 3.2% | Plan not stated | SEC |
| Dec 6, 2016 | Bitterman Kevin | Director, 10% owner | Form 4 sale | 130,000 | $2.1M | 3.2% | Unusual | SEC |
| Nov 23, 2016 | Polaris Venture Partners Founders' Fund VI, L.P. | 10% owner | Form 4 sale | 21,480 | $337k | 0.5% | Plan not stated | SEC |
| Nov 23, 2016 | Bitterman Kevin | Director, 10% owner | Form 4 sale | 21,480 | $337k | 0.5% | Plan not stated | SEC |
| Nov 22, 2016 | Polaris Venture Management Co. VI, L.L.C. | 10% owner | Form 4 sale | 12,819 | $202k | 0.3% | Plan not stated | SEC |
| Nov 22, 2016 | Bitterman Kevin | Director, 10% owner | Form 4 sale | 12,819 | $202k | 0.3% | Plan not stated | SEC |
| Nov 16, 2016 | Polaris Venture Management Co. VI, L.L.C. | 10% owner | Form 4 sale | 30,830 | $503k | 0.8% | Plan not stated | SEC |
| Nov 16, 2016 | Bitterman Kevin | Director, 10% owner | Form 4 sale | 30,830 | $503k | 0.8% | Plan not stated | SEC |
| Nov 15, 2016 | Polaris Venture Partners Founders' Fund VI, L.P. | 10% owner | Form 4 sale | 88,900 | $1.5M | 2.1% | Plan not stated | SEC |
| Nov 15, 2016 | Bitterman Kevin | Director, 10% owner | Form 4 sale | 88,900 | $1.5M | 2.1% | Plan not stated | SEC |
| Sep 8, 2016 | Bitterman Kevin | Director, 10% owner | Form 4 sale | 500,000 | $8.4M | 10.7% | Plan not stated | SEC |
| Sep 8, 2016 | Polaris Venture Partners Founders' Fund VI, L.P. | 10% owner | Form 4 sale | 500,000 | $8.4M | 10.7% | Plan not stated | SEC |
| Sep 6, 2016 | Starr Kevin P | 10% owner | Form 4 sale | 5,890 | $94k | 100.0% | Unusual | SEC |
| Aug 23, 2016 | Glucksmann Alexandra | Chief Operating Officer | Form 4 sale | 1,000 | $20k | 0.8% | Plan not stated | SEC |